[1]SyntheticCommunications,1980,vol.10,#3,p.167-174
[1]BioorganicandMedicinalChemistryLetters,2007,vol.17,#17,p.4982-4986
[1]Patent:WO2008/124393,2008,A1,.Locationinpatent:Page/Pagecolumn33-34
[1]BioorganicandMedicinalChemistryLetters,2008,vol.18,#7,p.2324-2328
[2]Patent:WO2008/124393,2008,A1,.Locationinpatent:Page/Pagecolumn33-34
[3]Patent:WO2018/39386,2018,A1,.Locationinpatent:Page/Pagecolumn138;139
[4]Patent:US2014/200215,2014,A1,.Locationinpatent:Paragraph0984;0986
[1]YakugakuZasshi/JournalofthePharmaceuticalSocietyofJapan,1950,vol.70,p.271,276 Chem.Abstr.,1951,p.10212
[1]YakugakuZasshi/JournalofthePharmaceuticalSocietyofJapan,1950,vol.70,p.271,276 Chem.Abstr.,1951,p.10212
[1]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1991,vol.30,p.494-498
[1]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1991,vol.30,p.494-498
[1]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1991,vol.30,p.494-498
Title: One scaffold, three binding modes: novel and selective pteridine reductase 1 inhibitors derived from fragment hits discovered by virtual screening.
Journal: Journal of medicinal chemistry 20090723